Literature DB >> 1747716

Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.

N A Laminski1, A M Meyers, M Kruger, M I Sonnekus, L P Margolius.   

Abstract

The presence of mild hyperoxaluria in recurrent calcium oxalate stone formers is controversial. The aim of this study was to identify recurrent stone formers with mild hyperoxaluria and to classify them further by assessing their response to a low oxalate diet. In addition, the prevalence of other risk factors for stone formation in this group of patients was investigated. A total of 207 consecutive patients with recurrent renal calculi were screened and 40 (19%) were found to have mild hyperoxaluria. Of these, 18 (45%) responded to dietary oxalate restriction by normalising their urinary oxalate. The remaining 22 patients were classified as having idiopathic hyperoxaluria and were subdivided into those in whom urinary oxalate excretion was consistently elevated in all specimens measured and those in whom the elevation was intermittent in nature. Dietary oxalate restriction had a partially beneficial effect in lowering oxalate excretion in the patients with persistent hyperoxaluria. No difference in urinary oxalate excretion was found after dietary restriction in the patients with intermittent hyperoxaluria. Other risk factors, including dietary, absorptive and renal hypercalciuria and hypocitraturia, were documented, the prevalence of which (65%) was not significantly different from that (62.5%) found in 40 age- and sex-matched calcium stone formers without hyperoxaluria. The prevalence of hyperuricosuria was significantly greater in patients with hyperoxaluria when compared with stone controls. Further studies are required to elucidate the underlying mechanisms of hyperoxaluria in recurrent stone formers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747716     DOI: 10.1111/j.1464-410x.1991.tb15383.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  12 in total

1.  Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.

Authors:  Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

2.  Protective impact of resveratrol in experimental rat model of hyperoxaluria.

Authors:  Taylan Oksay; Sedat Yunusoğlu; Mustafa Calapoğlu; I Aydın Candan; İbrahim Onaran; Osman Ergün; Alper Özorak
Journal:  Int Urol Nephrol       Date:  2017-02-09       Impact factor: 2.370

3.  Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance.

Authors:  Zeyad R Schwen; Julie M Riley; Yaniv Shilo; Timothy D Averch
Journal:  Urology       Date:  2013-09-17       Impact factor: 2.649

4.  Chitosan does not reduce post-prandial urinary oxalate excretion.

Authors:  Joshua Wolf; John R Asplin; David S Goldfarb
Journal:  Urol Res       Date:  2006-02-28

Review 5.  Effectiveness of Treatment Modalities on Kidney Stone Recurrence.

Authors:  Anna L Zisman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-22       Impact factor: 8.237

Review 6.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 7.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

8.  Nutrition and urinary calcium stone formation in northwestern India: a case control study.

Authors:  A K Pendse; R Ghosh; D V Ramavataram; P P Singh
Journal:  Urol Res       Date:  1996

Review 9.  Pharmacology of stone disease.

Authors:  Khashayar Sakhaee
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

Review 10.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.